TauroPharm Australia

TauroPharm is a specialized pharmaceutical and medical device company focused on the development and distribution of innovative lock solutions for central venous access devices. The company's flagship product line, TauroLock, is designed to prevent catheter-related bloodstream infections (CRBSI) and maintain catheter patency by combining antimicrobial agents with anticoagulants. TauroPharm's products are widely used in dialysis, oncology, and parenteral nutrition to reduce complications associated with long-term catheterization. While headquartered in Germany, the company operates globally through a network of distributors, including dedicated representation in Australia to serve the regional healthcare market.